Carme Serra Comas

Title: Carme Serra Comas: Innovator in Pharmaceutical Compounds

Introduction

Carme Serra Comas is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzyme-associated disorders. With a total of 2 patents to her name, her work is paving the way for innovative treatments in various medical conditions.

Latest Patents

Carme's latest patents focus on inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1. These compounds, derived from perhydroquinoline and perhydroisoquinoline, serve as active pharmaceutical ingredients. They are particularly useful for the prophylaxis or treatment of diseases associated with the 11-beta-HSD1 enzyme, including glaucoma, elevated ocular pressure, metabolic disorders, obesity, metabolic syndrome, dyslipidemia, hypertension, diabetes, atherosclerosis, Cushing's syndrome, psoriasis, rheumatoid arthritis, cognitive disorders, Alzheimer's disease, and neurodegeneration.

Career Highlights

Carme Serra Comas is currently employed at Laboratorios Salvat, S.A. Her work at this esteemed company has allowed her to focus on innovative pharmaceutical research and development. She has been instrumental in advancing the understanding of enzyme-related disorders and their treatments.

Collaborations

Throughout her career, Carme has collaborated with notable colleagues, including Juan Lorenzo Catena Ruiz and Oscar Rey Puiggros. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Carme Serra Comas is a pioneering inventor whose work in pharmaceutical compounds is making a significant impact on the treatment of various diseases. Her innovative approach and dedication to research continue to inspire advancements in the medical field.